← TrialMatch
HomeTrials

Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ab

The LockeT II study is a single center, prospective randomized study. It is intended to study the effectiveness of using LockeT device to gain hemostasis after venous procedures as compared to Manual Compression (MC). Approximately 110 patients will be enrolled.

Condition(s)Atrial Fibrillation, Hemostasis
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThe LockeT II study is a single center, prospective randomized study. It is intended to study the effectiveness of using LockeT device to gain hemostasis after venous procedures as compared to Manual Compression (MC). Approximately 110 patients will be enrolled.
Who can participateInclusion Criteria: * Must be at least 18 years of age * Be able to provide consent * Presenting for planned procedures that require percutaneous venous punctures, such as atrial fibrillation radiofrequency ablation, and where the physician utilizes a LockeT device or MC to close the wound. Exclusion Criteria: * Under the age of 18 * Unable to or unwilling to provide consent * Cannot comply with study requirements * Not undergoing procedures that require a percutaneous venous puncture or planned access to the left atrium and/or ventricle * Subjects whose physician does not use LockeT or MC to close the venous puncture. * Patient is currently pregnant, as evidenced by positive urine Beta-HCG. (Urine Beta Human chorionic gonadotropin (HCG) will be checked in all females of the reproductive a
Ages18 Years
SexAll
Lead sponsorKansas City Heart Rhythm Research Foundation
LocationsOverland Park, Kansas, United States; Overland Park, Kansas, United States; Independence, Missouri, United States; Independence, Missouri, United States; Kansas City, Missouri, United States; Kansas City, Missouri, United States
Start date2023-10-02
NCT IDNCT06078735
Official listinghttps://clinicaltrials.gov/study/NCT06078735

🔍 Search all trials →